The article entitled “Hematocrit Compensation in Electrochemical Blood Glucose Monitoring Systems” by Teodorczyk and colleagues in this issue of Journal of Diabetes Science and Technology demonstrates that the OneTouch® Verio™ glucose meter meets current regulatory expectations for glucose meter performance and is relatively free from interference by hematocrit. The lack of influence of hematocrit on whole blood glucose results is a valuable attribute for hospital applications, where greater variation of hematocrit among patients is anticipated. The choice of reference method for evaluation of glucose meters is an important consideration, and it is not clear to what extent reference methods used to evaluate glucose meters are also free from hematocrit interferences.
D'OrazioPBurnettRWFogh-AndersenNJacobsEKuwaKKülpmannWRLarssonLLewenstamAMaasAHMagerGNaskalskiJWOkoroduduAO; International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC recommendation on reporting results for blood glucose. Clin Chem Lab Med.2006;44 (12): 1486–90.
3.
Fogh-AndersenND'OrazioP. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem.1998;44 (3): 655–9.
4.
LyonMELyonAW. Patient acuity exacerbates discrepancy between whole blood and plasma methods through error in molality to molarity conversion: “Mind the gap!”. Clin Biochem.2011;44 (5–6): 412–7.
5.
FrickeH. The electric capacity of suspensions of red corpuscles of a dog. Phys Rev.1925;26 (5): 682–7.
6.
LyonMEDuBoisJAFickGHLyonAW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate. J Diabetes Sci Technol.2010;4 (6): 1479–94.
